StockData
ZVSAOTCPharmaceutical PreparationsFiscal year ends December 31

ZyVersa Therapeutics, Inc.

Financials through Q1 FY2026, quarter ended Mar 31, 2026Last filing: 10-Q on May 13, 2026
$0.05+0.00 (0.00%)

Close on Oct 19, 2026

Market cap
$388.60K
P/E (TTM)
–
Dividend yield
–

ZyVersa Therapeutics, Inc. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

ZyVersa Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.